The global drug eluting beads market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of patients suffering from cancer and other chronic diseases, which in turn leads to an increase in demand for medical devices such as drug eluting beads.
Oncozene Beads: Oncozene Beads are used for treating cancerous tumors by releasing chemotherapeutic drugs into the tumor cells. These beads are made up of a polymer that releases drugs over time and can be implanted into the tumor site or near it. Quadra Sphere: Quadra Sphere is a type of drug eluting bead that has four compartments with each compartment containing one type of chemotherapeutic agent. LC Beads: LC Beads are used for treating cancers by releasing chemotherapeutic drugs into the tumor cells through diffusion across its surface membrane layer, which allows them to release their contents gradually over time without any external stimulus or intervention required on behalf of the patient or physician.
- Drug eluting beads are also used in the treatment of cancerous tumors, which has led to an increase in demand for these products over the past few years due to an increase in cancer cases worldwide.
- The introduction and approval of new drugs that can be delivered using drug eluting beads has also contributed significantly towards market growth over the past few years as it provides physicians with more options when treating patients suffering from various types of cancers or chronic diseases such as diabetes or hypertension .
Industry Growth Insights published a new data on “Drug Eluting Beads Market”. The research report is titled “Drug Eluting Beads Market research by Types (Oncozene Beads, Quadra Sphere, LC Beads, Others), By Applications (Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers), By Players/Companies Biocompatibles, BTG International, Merit Medical Systems, CeloNova BioSciences, ABK Biomedical, Boston Scientific, Medtronic, Merit Medical Systems, Surefire Medical, Terumo”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Drug Eluting Beads Market Research Report
By Type
Oncozene Beads, Quadra Sphere, LC Beads, Others
By Application
Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers
By Companies
Biocompatibles, BTG International, Merit Medical Systems, CeloNova BioSciences, ABK Biomedical, Boston Scientific, Medtronic, Merit Medical Systems, Surefire Medical, Terumo
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Drug Eluting Beads Market Report Segments:
The global Drug Eluting Beads market is segmented on the basis of:
Types
Oncozene Beads, Quadra Sphere, LC Beads, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Specialized Clinics, Research Centers, Ambulatory Surgical Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biocompatibles
- BTG International
- Merit Medical Systems
- CeloNova BioSciences
- ABK Biomedical
- Boston Scientific
- Medtronic
- Merit Medical Systems
- Surefire Medical
- Terumo
Highlights of The Drug Eluting Beads Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Oncozene Beads
- Quadra Sphere
- LC Beads
- Others
- By Application:
- Hospitals
- Specialized Clinics
- Research Centers
- Ambulatory Surgical Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Drug Eluting Beads Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Drug eluting beads are a type of drug delivery system that uses a polymer to encapsulate drugs and release them over time. The beads can be loaded with different types of drugs, and when they reach the target area, the drug will slowly release over time. This allows for precise dosing and improved patient compliance.
Some of the major players in the drug eluting beads market are Biocompatibles, BTG International, Merit Medical Systems, CeloNova BioSciences, ABK Biomedical, Boston Scientific, Medtronic, Merit Medical Systems, Surefire Medical, Terumo.
The drug eluting beads market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Drug Eluting Beads Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Drug Eluting Beads Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Drug Eluting Beads Market - Supply Chain
4.5. Global Drug Eluting Beads Market Forecast
4.5.1. Drug Eluting Beads Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Drug Eluting Beads Market Size (000 Units) and Y-o-Y Growth
4.5.3. Drug Eluting Beads Market Absolute $ Opportunity
5. Global Drug Eluting Beads Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Drug Eluting Beads Market Size and Volume Forecast by Type
5.3.1. Oncozene Beads
5.3.2. Quadra Sphere
5.3.3. LC Beads
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Drug Eluting Beads Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Drug Eluting Beads Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Specialized Clinics
6.3.3. Research Centers
6.3.4. Ambulatory Surgical Centers
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Drug Eluting Beads Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Drug Eluting Beads Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Drug Eluting Beads Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Drug Eluting Beads Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Drug Eluting Beads Demand Share Forecast, 2019-2026
9. North America Drug Eluting Beads Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Drug Eluting Beads Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Drug Eluting Beads Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Specialized Clinics
9.4.3. Research Centers
9.4.4. Ambulatory Surgical Centers
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Drug Eluting Beads Market Size and Volume Forecast by Type
9.7.1. Oncozene Beads
9.7.2. Quadra Sphere
9.7.3. LC Beads
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Drug Eluting Beads Demand Share Forecast, 2019-2026
10. Latin America Drug Eluting Beads Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Drug Eluting Beads Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Drug Eluting Beads Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Specialized Clinics
10.4.3. Research Centers
10.4.4. Ambulatory Surgical Centers
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Drug Eluting Beads Market Size and Volume Forecast by Type
10.7.1. Oncozene Beads
10.7.2. Quadra Sphere
10.7.3. LC Beads
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Drug Eluting Beads Demand Share Forecast, 2019-2026
11. Europe Drug Eluting Beads Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Drug Eluting Beads Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Drug Eluting Beads Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Specialized Clinics
11.4.3. Research Centers
11.4.4. Ambulatory Surgical Centers
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Drug Eluting Beads Market Size and Volume Forecast by Type
11.7.1. Oncozene Beads
11.7.2. Quadra Sphere
11.7.3. LC Beads
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by ype
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Drug Eluting Beads Demand Share, 2019-2026
12. Asia Pacific Drug Eluting Beads Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Drug Eluting Beads Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Drug Eluting Beads Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Specialized Clinics
12.4.3. Research Centers
12.4.4. Ambulatory Surgical Centers
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Drug Eluting Beads Market Size and Volume Forecast by Type
12.7.1. Oncozene Beads
12.7.2. Quadra Sphere
12.7.3. LC Beads
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Drug Eluting Beads Demand Share, 2019-2026
13. Middle East & Africa Drug Eluting Beads Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Drug Eluting Beads Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Drug Eluting Beads Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Specialized Clinics
13.4.3. Research Centers
13.4.4. Ambulatory Surgical Centers
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Drug Eluting Beads Market Size and Volume Forecast by Type
13.7.1. Oncozene Beads
13.7.2. Quadra Sphere
13.7.3. LC Beads
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Drug Eluting Beads Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Drug Eluting Beads Market: Market Share Analysis
14.2. Drug Eluting Beads Distributors and Customers
14.3. Drug Eluting Beads Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Biocompatibles
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. BTG International
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merit Medical Systems
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. CeloNova BioSciences
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. ABK Biomedical
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Boston Scientific
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Medtronic
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Merit Medical Systems
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Surefire Medical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Terumo
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
